Navigation Links
Tamiflu Shortage Can Be Better Handled By Combining It With Probenecid

Drug Synergism refers to the enhancement in action or effect of a particular drug than the individual effect of both the drugs combined. The phenomenon could be exploited in the present scenario where the avian bird flu is posing a serious threat across different regions of the globe. //

Tamiflu is a prescribed drug for seasonal flu, because it will be a first line of defense if the H5N1 bird flu circulating in Asia and reported in other areas mutates into a human pandemic strain. More than 60 people have died from the H5N1 strain in Asia. Medical experts fear it could spark a global pandemic if it mutates into a highly infectious virus in humans.

President George W. Bush asked the U.S. Congress for $7.1 billion on Tuesday to prepare for a pandemic flu, including $1.2 billion for 20 million doses of a vaccine against H5N1 bird flu.

Joe Howton, a medical director at the Adventist Medical Center in Portland, Oregon believes probenecid, a treatment for gout that is used with some antibiotics to boost effectiveness, could have a similar impact with Tamiflu. The idea stuck him when he noticed that giving Tamiflu with probenecid doubles the number of hours its active ingredient is in the blood.

Probenecid is used for the treatment of Gout and works by preventing the drugs from being removed from the body by the process of excretion. In other words it increases the bioavailability of the drugs. The effectiveness of the drug combination against a pandemic strain has not been established. However, it is considered the best option until a vaccine can be developed.

The move also seems sensible enough particularly when Governments are stockpiling Tamiflu (that is in scarce supply) to manage influenza pandemic in case the need arises. The acute shortage can be better handled with the innovative proposal. If it were proved right, half a dose of Tamiflu with probenecid would be as effective as a full dose without it.

But Ro che, the manufacturer of the drug said it could not advocate combined treatment because of the lack of clinical data and regulatory approval. Given where we are, with the potential for a pandemic, the clearest vision we can have is to dramatically increase the availability of this drug and make all information available, said David Reddy, Roche's influenza pandemic task force leader.
'"/>




Related medicine news :

1. India To Procure 1 Million Doses Of Tamiflu
2. US Reviews Risks Of Tamiflu After 12 Children Die
3. US Regulator Sees No Link Between Tamiflu And Japan Deaths
4. Roche confirms Tamiflu production talks in US
5. Dosage Of Tamiflu Sought To Be Increased
6. Tamiflu Fails To Save Two Lives
7. Christmas trees to yield key Tamiflu ingredient
8. India to produce Tamiflu generic ‘Oseltamivir
9. A success for the Indian pharmacy: gets licence to manufacture Tamiflu
10. Hyderabad Firm To Manufacture Tamiflu In India
11. Tamiflu substrate produced from Bioengineered Bacteria
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... ... 28, 2017 , ... The Executives, Staff & Clients of MGE: Management Experts ... for Tots Literacy Campaign at their Semi-Annual Graduation and Fundraiser Event at MGE’s St. ... ranks at number 14 internationally in literacy. Statistically, a direct relation can be a ...
(Date:3/28/2017)... ... 2017 , ... Public relations pros work hard to earn placements and ... While many results are clear, much of PR is hard to quantify. Goal-setting and ... to measurement, firms should always take an all-inclusive approach that takes both traditional and ...
(Date:3/28/2017)... ... March 28, 2017 , ... Thank you to all who ... 8-10. , This event was exclusive to providers and offered an opportunity to ... took place at the Manchester Grand Hyatt where attendees gathered for a lively discussion ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... patients for clear braces. People who want straight teeth without the extensive time ... in Clearwater, FL, without acquiring a referral. A custom-designed series of virtually ...
(Date:3/27/2017)... ... March 27, 2017 , ... This is the ... popHealth Community in 2014. It is the culmination of collaborative efforts by ... Project Group. OSEHRA Organizational Member Zato Health co-funded the ONC certification and provided ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... March 28, 2017 Elysium Health ... Cambridge academic scientists ... The Milner Therapeutics Institute today announces Elysium Health ... has committed significant investment for collaborative projects with academic researchers ... years. This is the first major research investment outside the ...
(Date:3/27/2017)... TEL-AVIV, Israel , March 27, 2017 /PRNewswire/ ... TASE: THXBY), a specialty clinical-stage pharmaceutical company specializing in the ... of its public offering in the ... Shares (ADSs), each ADS representing 40 ordinary shares ... per ADS. In addition, Therapix has granted the ...
(Date:3/27/2017)... March 27, 2017 LightIntegra Technology Inc. today ... "Bill" Dubiel as President and Chief Executive Officer effective ... the Board of Directors of LightIntegra. Paul Geyer ... of LightIntegra. "This is the perfect ... Chief Executive Officer. We,ve selected a very strong leader ...
Breaking Medicine Technology: